Public consultations on active substances

EFSA provides access to the draft assessment report submitted by a designated rapporteur Member State for the EU peer review of existing and new active substances used in plant protection products. For new active substances reviewed under Regulation (EC) No 1107/2009, EFSA makes the summary dossiers publicly available. Applications and summary dossiers for renewal of approval reviewed under that Regulation are also made available to the public by EFSA. The documents are made available in accordance with the EU legislative framework.

When a rapporteur Member State assessment report becomes available, a public consultation period is launched via the EFSA website.

Instructions and guidance documents on how to submit comments to EFSA are available below.

How to submit comments 

  • Comments on rapporteur Member State assessment reports should be sent by email to EFSA (DAR_consultation@efsa.europa.eu) no later than the deadline given for the particular active substance. Please use the electronic template provided with the documents for submission of comments.
  • We regret that comments received by EFSA after the respective submission deadline cannot be taken into account.
  • EFSA reserves the right to reject comments not relating to the risk assessment of the active substance. A guidance document is available on how to provide comments on rapporteur Member State assessment reports.

How to identify confidential information

  • Article 63(2) of the Regulation (EC) No 1107/2009 lays down what information shall normally be deemed to undermine the protection of the commercial interests or of the privacy and the integrity of the individuals concerned.
  • An overview document explains how the process of identification and removal of confidential information is performed for the summary dossier, the draft assessment report, the EFSA conclusion and the application for renewal of approval.
    Removal of confidential information (0.2 Mb)
  • A form is available for identification, justification and evaluation of the claims for confidentiality
    Request for information to remain confidential (0.1 Mb)